Home Compare MDT vs TMO
Stock Comparison · Single-driver result

Medtronic vs Thermo Fisher Scientific: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Thermo Fisher Scientific carrying a narrow edge on profitability. Medtronic still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Profitability still does most of the heavy lifting in this comparison.

Trajectory Similarity
0.75
Similar
Peer-set rank: #3
within Medtronic plc's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

Most of the shared profile comes through margin consistency and revenue stability.

Similarity drivers
margin consistencyrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MDT
Medtronic plc
51
Peer-Score
Signal qualityHigh
vs
TMO
Thermo Fisher Scientific Inc.
54
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: MDT vs TMO Profitability 24 50 Stability 72 62 Valuation 74 65 Growth 33 35 MDT TMO
Gap Ranking
#1 Profitability +26
#2 Stability +10
#3 Valuation +9
#4 Growth +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MDT and TMO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MDTTMO Relative valuation Structural strength

The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Thermo Fisher Scientific Inc. sits in the stronger part of the group on profitability, while Medtronic plc is closer to mid-pack.
Stability
Both rank well on stability, but Medtronic plc still sits higher.
Profitability — Dominant Gap
MDT
24
TMO
50
Gap+26in favour of TMO

The clearest distance comes from a stronger profitability profile.

What keeps the gap from being one-sided

Medtronic plc still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

The main read on profitability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the MDT vs TMO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-driven comparisons

Explore how MDT and TMO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.